Vygon Asia donates chemo ports to Mount Miriam Cancer Hospital in Malaysia
Value Life – One Port One Life Program
Penang, Malaysia, June 11, 2019 – Vygon Asia today announces that it has donated 50 Vygon Polysite ISP implantable ports for patients undergoing chemotherapy at the Mount Miriam Cancer Hospital under the One Port One Life program.
Vygon’s Polysite ISP port is usually offered when a patient’s medical treatment requires regular administration of medicines and infusions, such as cancer patients undergoing chemotherapy. During the procedure veins can undergo thinning, which means that locating veins to inject medicine and draw blood can become very difficult, even for qualified medical personnel. Without the help of chemo ports, repeated jabbing might be inevitable for locating these very thin veins. Chemo ports are a pain-free and efficient solution for addressing this issue.
“We believe it is of the utmost importance to support local hospitals whose mission is to treat underprivileged cancer patients with the latest technology otherwise unaffordable to them,” said Thanapathy Kumaraiah, regional director, Asia-Oceanic at Vygon. “Vygon is committed to working with other hospitals, not only in Malaysia but in the whole region.”
“Thanks to Vygon’s donation, for the first time this hospital is able to offer free chemo ports for underprivileged patients without having to tap into its Needy Cancer Patients Fund. Support from Vygon will help us to leverage our charitable mission in providing optimal cancer care for this underprivileged group,” said Joan Lim-Choong, chief executive officer of Mount Miriam Cancer Hospital.
“We are thrilled to launch this One Port One Life program in Asia to support health centres and hospitals in the region. In addition to oncology or neonatal product donations, we are also committed to providing adequate training to healthcare practitioners for a better patients’ outcome,” added Christophe Deffontaines, VP Asia, Vygon.
About Mount Miriam Cancer Hospital
Mount Miriam Cancer Hospital is a not-for-profit, mission driven, cancer hospital – which aspires to serve all cancer patients regardless of their financial status, belief or nationality, with the best and most affordable cancer treatment and cancer care. Mount Miriam’s vision is that no cancer patient should be denied treatment. We believe that the access to cancer treatment and care must be based on need, not the ability to afford the rising medical cost. Every year, the hospital disburses an average of RM 1 million ($240K) from the Needy Cancer Patient Fund to help needy patients. Last year, a total of RM 1,579,712.00 ($380K) was disbursed to financially assist 272 deserving cancer patients.
About Vygon Group
Vygon designs, manufactures and markets high-tech single-use medical devices for healthcare professionals in hospital and for private and independent practitioners. Vygon is a world leader within this industry, offering a wide range of products in a number of clinical specialties. Organized in five business units (Intensive Care – Neonatology, Enteral & Obstetrics – Intravascular Therapies – Cardiovascular & Surgery – Anesthesia & Emergency), Vygon combines local and international in-depth expertise and know-how in each individual field. With expertise right along the value chain, from product design to the delivery of training for medical personnel, Vygon provides health care professionals with effective and innovative products tailored to their needs and those of their patients, for optimum use and safety. The company distributes over 205 million products a year in more than 120 countries through its network of 27 subsidiaries and 331 distributors. Vygon products display the CE and/or FDA mark and are manufactured in the group’s eight factories in Europe, the USA and Colombia. A family company founded in 1962, Vygon is based in Ecouen, in France’s Greater Paris region. It is a mid-sized business employing 2,350 staff worldwide. The turnover in 2018 was €323 million ($365M), with 81% of this derived from Vygon’s international business.